{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:28:14Z","timestamp":1795195694906,"version":"4.10.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005979","name":"Lustgarten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009730","name":"EIF | Stand Up To Cancer","doi-asserted-by":"publisher","award":["SU2C-AACR-DT25-17"],"award-info":[{"award-number":["SU2C-AACR-DT25-17"]}],"id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with pancreatic cancer commonly develop weight loss and muscle wasting. Whether adipose tissue and skeletal muscle losses begin before diagnosis and the potential utility of such losses for earlier cancer detection are not well understood. We quantify skeletal muscle and adipose tissue areas from computed tomography (CT) imaging obtained 2 months to 5 years before cancer diagnosis in 714 pancreatic cancer cases and 1748 matched controls. Adipose tissue loss is identified up to 6 months, and skeletal muscle wasting is identified up to 18 months before the clinical diagnosis of pancreatic cancer and is not present in the matched control population. Tissue losses are of similar magnitude in cases diagnosed with localized compared with metastatic disease and are not correlated with at-diagnosis circulating levels of CA19-9. Skeletal muscle wasting occurs in the 1\u20132 years before pancreatic cancer diagnosis and may signal an upcoming diagnosis of pancreatic cancer.<\/jats:p>","DOI":"10.1038\/s41467-023-40024-3","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T15:04:32Z","timestamp":1689692672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1199-5958","authenticated-orcid":false,"given":"Ana","family":"Babic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5085-3904","authenticated-orcid":false,"given":"Michael H.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilak K.","family":"Sundaresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren K.","family":"Brais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-1608","authenticated-orcid":false,"given":"Leah","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamol","family":"Gurung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Harrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khoschy","family":"Schawkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah H.","family":"Biller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6184-9273","authenticated-orcid":false,"given":"Matthew B.","family":"Yurgelun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-1494","authenticated-orcid":false,"given":"Kimmie","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0701-6203","authenticated-orcid":false,"given":"Andrew J.","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1293-2097","authenticated-orcid":false,"given":"Sangeeta N.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6702-4192","authenticated-orcid":false,"given":"Matthew G.","family":"Vander Heiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5599-8387","authenticated-orcid":false,"given":"Stephen K.","family":"Van Den Eeden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette J.","family":"Caan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0455-1032","authenticated-orcid":false,"given":"Brian M.","family":"Wolpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"key":"40024_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913\u20132921 (2014).","journal-title":"Cancer Res."},{"key":"40024_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"40024_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41575-021-00431-7","volume":"18","author":"J Encarnacion-Rosado","year":"2021","unstructured":"Encarnacion-Rosado, J. & Kimmelman, A. C. Harnessing metabolic dependencies in pancreatic cancers. Nat. Rev. Gastroenterol. Hepatol. 18, 482\u201392 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"40024_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","volume":"134","author":"ST Chari","year":"2008","unstructured":"Chari, S. T. et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134, 95\u2013101 (2008).","journal-title":"Gastroenterology"},{"key":"40024_CR5","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1245\/s10434-021-09861-8","volume":"28","author":"JJ Hue","year":"2021","unstructured":"Hue, J. J. et al. Weight loss as an untapped early detection marker in pancreatic and periampullary cancer. Ann. Surg. Oncol. 28, 6283\u201392 (2021).","journal-title":"Ann. Surg. Oncol."},{"key":"40024_CR6","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/ajg.2009.253","volume":"104","author":"R Pannala","year":"2009","unstructured":"Pannala, R. et al. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am. J. Gastroenterol. 104, 2318\u20132325 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"40024_CR7","doi-asserted-by":"publisher","first-page":"e202948","DOI":"10.1001\/jamaoncol.2020.2948","volume":"6","author":"C Yuan","year":"2020","unstructured":"Yuan, C. et al. Diabetes, weight change, and pancreatic cancer risk. JAMA Oncol. 6, e202948 (2020).","journal-title":"JAMA Oncol."},{"key":"40024_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/MOG.0000000000000763","volume":"37","author":"BU Wu","year":"2021","unstructured":"Wu, B. U. Diabetes and pancreatic cancer: recent insights with implications for early diagnosis, treatment and prevention. Curr. Opin. Gastroenterol. 37, 539\u201343 (2021).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"40024_CR9","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41416-021-01301-4","volume":"124","author":"M Kordes","year":"2021","unstructured":"Kordes, M., Larsson, L., Engstrand, L. & Lohr, J. M. Pancreatic cancer cachexia: three dimensions of a complex syndrome. Br. J. Cancer 124, 1623\u201336 (2021).","journal-title":"Br. J. Cancer"},{"key":"40024_CR10","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nm.3686","volume":"20","author":"JR Mayers","year":"2014","unstructured":"Mayers, J. R. et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat. Med. 20, 1193\u20131198 (2014).","journal-title":"Nat. Med."},{"key":"40024_CR11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-018-0235-7","volume":"558","author":"LV Danai","year":"2018","unstructured":"Danai, L. V. et al. Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature 558, 600\u201304 (2018).","journal-title":"Nature"},{"key":"40024_CR12","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.gassur.2006.08.001","volume":"10","author":"J Matsumoto","year":"2006","unstructured":"Matsumoto, J. & Traverso, L. W. Exocrine function following the whipple operation as assessed by stool elastase. J. Gastrointest. Surg. 10, 1225\u20131229 (2006).","journal-title":"J. Gastrointest. Surg."},{"key":"40024_CR13","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1053\/j.gastro.2019.01.039","volume":"156","author":"RP Sah","year":"2019","unstructured":"Sah, R. P. et al. Phases of metabolic and soft tissue changes in months preceding a diagnosis of pancreatic ductal adenocarcinoma. Gastroenterology 156, 1742\u201352 (2019).","journal-title":"Gastroenterology"},{"key":"40024_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park, W., Chawla, A. & O\u2019Reilly, E. M. Pancreatic cancer: a review. JAMA 326, 851\u2013862 (2021).","journal-title":"JAMA"},{"key":"40024_CR15","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1200\/JCO.2005.05.3934","volume":"24","author":"CR Ferrone","year":"2006","unstructured":"Ferrone, C. R. et al. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J. Clin. Oncol. 24, 2897\u20132902 (2006).","journal-title":"J. Clin. Oncol."},{"key":"40024_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/00000658-199204000-00008","volume":"215","author":"F Tian","year":"1992","unstructured":"Tian, F., Appert, H. E., Myles, J. & Howard, J. M. Prognostic value of serum CA 19-9 levels in pancreatic adenocarcinoma. Ann. Surg. 215, 350\u2013355 (1992).","journal-title":"Ann. Surg."},{"key":"40024_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/MPA.0b013e318220816a","volume":"40","author":"PA Hart","year":"2011","unstructured":"Hart, P. A. et al. Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus. Pancreas 40, 768\u2013772 (2011).","journal-title":"Pancreas"},{"key":"40024_CR18","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2337\/db16-1477","volume":"66","author":"DK Andersen","year":"2017","unstructured":"Andersen, D. K. et al. Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes 66, 1103\u201310 (2017).","journal-title":"Diabetes"},{"key":"40024_CR19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","volume":"129","author":"ST Chari","year":"2005","unstructured":"Chari, S. T. et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129, 504\u2013511 (2005).","journal-title":"Gastroenterology"},{"key":"40024_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2042-6410-3-13","volume":"3","author":"K Karastergiou","year":"2012","unstructured":"Karastergiou, K., Smith, S. R., Greenberg, A. S. & Fried, S. K. Sex differences in human adipose tissues - the biology of pear shape. Biol. Sex. Differ. 3, 13 (2012).","journal-title":"Biol. Sex. Differ."},{"key":"40024_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0899-9007(03)00061-3","volume":"19","author":"UG Kyle","year":"2003","unstructured":"Kyle, U. G., Schutz, Y., Dupertuis, Y. M. & Pichard, C. Body composition interpretation. Contributions of the fat-free mass index and the body fat mass index. Nutrition 19, 597\u2013604 (2003).","journal-title":"Nutrition"},{"key":"40024_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-018-1404-2","volume":"14","author":"NP Long","year":"2018","unstructured":"Long, N. P. et al. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer. Metabolomics 14, 109 (2018).","journal-title":"Metabolomics"},{"key":"40024_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein, A. P. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat. Rev. Gastroenterol. Hepatol. 18, 493\u2013502 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"40024_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1146\/annurev.nutr.17.1.527","volume":"17","author":"SB Heymsfield","year":"1997","unstructured":"Heymsfield, S. B., Wang, Z., Baumgartner, R. N. & Ross, R. Human body composition: advances in models and methods. Annu. Rev. Nutr. 17, 527\u2013558 (1997).","journal-title":"Annu. Rev. Nutr."},{"key":"40024_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13539-012-0086-2","volume":"4","author":"A Nedergaard","year":"2013","unstructured":"Nedergaard, A., Karsdal, M. A., Sun, S. & Henriksen, K. Serological muscle loss biomarkers: an overview of current concepts and future possibilities. J. Cachexia Sarcopenia Muscle 4, 1\u201317 (2013).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"40024_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1148\/radiol.2020201640","volume":"298","author":"K Magudia","year":"2021","unstructured":"Magudia, K. et al. Population-scale CT-based body composition analysis of a large outpatient population using deep learning to derive age-, sex-, and race-specific reference curves. Radiology 298, 319\u201329 (2021).","journal-title":"Radiology"},{"key":"40024_CR27","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","volume":"97","author":"W Shen","year":"2004","unstructured":"Shen, W. et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J. Appl. Physiol. 97, 2333\u20132338 (2004).","journal-title":"J. Appl. Physiol."},{"key":"40024_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/ajcn\/80.2.271","volume":"80","author":"W Shen","year":"2004","unstructured":"Shen, W. et al. Visceral adipose tissue: relations between single-slice areas and total volume. Am. J. Clin. Nutr. 80, 271\u2013278 (2004).","journal-title":"Am. J. Clin. Nutr."},{"key":"40024_CR29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/obr.12358","volume":"17","author":"SB Heymsfield","year":"2016","unstructured":"Heymsfield, S. B., Peterson, C. M., Thomas, D. M., Heo, M. & Schuna, J. M. Jr. Why are there race\/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review. Obes. Rev. 17, 262\u2013275 (2016).","journal-title":"Obes. Rev."},{"key":"40024_CR30","first-page":"153","volume":"58","author":"JD Legler","year":"1998","unstructured":"Legler, J. D. & Rose, L. C. Assessment of abnormal growth curves. Am. Fam. Physician 58, 153\u2013158 (1998).","journal-title":"Am. Fam. Physician"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40024-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40024-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40024-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T15:05:57Z","timestamp":1689692757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40024-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40024"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-40024-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]},"assertion":[{"value":"21 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.G.V.H. is a scientific advisor for Agios Pharmaceuticals, iTeos Therapeutics, Sage Therapeutics, Faeth Therapeutics, Droia Ventures, and Auron Therapeutics on topics unrelated to the presented work. B.M.W. received research funding from Celgene, Eli Lilly, Novartis, and Revolution Medicine and consulting fees from Celgene, Grail, Mirati, and Third Rock Ventures unrelated to the presented work. M.B.Y. received research grant from Janssen Pharmaceuticals and fees for peer review services from UpToDate, unrelated to the presented work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4317"}}